Effects of the multidrug resistance modulator HZ08 on the apoptosis pathway in human chronic leukaemia cell line K562/A02

Abstract

Cancer fails to respond to chemotherapy by acquiring multidrug resistance in over 90% of patients. A previous study revealed that multidrug resistance modulator HZ08 had great multidrug resistance reversal effect in vitro and in vivo. It could enhance adriamycin (doxorubicin) induced intrinsic apoptosis pathway and rectify cell cycle and some apoptosis related proteins in human breast resistant cancer MCF-7/ADM cells. This study detected Rh l23 accumulation to assess the effect of HZ08 on P-glycoprotein function in human chronic leukaemia cell line K562/A02. Moreover, mitochondria membrane potential, cytochrome c release and caspase-3 activity were analyzed for HZ08 treatment with or without vincristine. Since pretreatment with HZ08 could also reverse the multidrug resistance to vincristine in K562/A02 cells, the individual influence of HZ08 was further detected on apoptotic regulator like Bcl-2, Bax, p53, cell cycle checkpoints and proliferation regulatory factors like survivin, hTERT, c-Myc, c-Fos, c-Jun. Finally, it revealed that HZ08 increased vincristine induced activation in intrinsic apoptosis pathway by inhibition of P-gp mediated efflux. In addition, the outstanding reversal effect of HZ08 should also attribute to its individual effect on apoptosis and proliferation related regulatory factors. It renders HZ08 possibility of application in pretreatment to reverse multidrug resistance while avoiding unexpected drug interactions and accumulative toxicity.

Key words

Apoptosis - Cancer - Human telomerase reverse transcriptase - HZ08 - K562/A02 cells - Multidrug resistance

• References

• 1 Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008; Nov 34 (7) 592-602
• 2 McDevitt CA, Callaghan R. How can we best use structural information on P-glycoprotein to design inhibitors?. Pharmacol Ther. 2007; Feb 113 (2) 429-41
• 3 Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y et al. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCBl)-mediated multidrug resistance in cancer cells. Biochem Pharmacol. 2010; Nov 80 (10) 1497-506
• 4 Li L, Pan Q, Sun M, Lu Q, Hu X. Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1. Life Sci. 2007; Jan 80 (8) 741-8
• 5 Makin G, Dive C. Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy. Trends Mol Med. 2003; Jun 9 (6) 251-5
• 6 Maire MA, Rast C, Vasseur P. Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells. Toxicol Lett. 2005; Sep 158 (3) 237-45
• 7 Ong RC, Lei J, Lee RK, Cheung JY, Fung KP et al. Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells. Cancer Lett. 2008; Mar 261 (2) 158-64
• 8 Jagadeesh S, Kyo S, Banerjee P P. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 2006; Feb 66 (4) 2107-15
• 9 Strasser A, Harris A W, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-in-dependent mechanisms inhibitable by Bcl-2. Cell. 1994; Oct 79 (2) 329-39
• 10 Sugimoto C, Fujieda S, Seki M, Sunaga H, Fan GK et al. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo. Int J Cancer. 1999; Sep 82 (6) 860-7
• 11 Fang W, Li Y, Cai Y, Kang K, Yan F et al. Substituted tetra-hydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. J Pharm Pharmacol. 2007; Dec 59 (12) 1649-55
• 12 Yan F, Li Y, Wang Q, Fang W, Kang K et al. Effects of HZ08, a novel P-glycoprote in inhibitor, on the reversa l of P-glycoprote inmediated multidrug resistance in nude mice and cytochrome P2450 activities in rat liver microsomes. J China Pharm Univ. 2008; 39 (5) 447-52
• 13 Cen J, Qi Y, Tao YF, Deng Y, Fang WR et al. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM. Eur J Pharmacol. 2010; Nov 647 (l–3) 21-30
• 14 Yan F, Jiang Y, Li YM, Zhen X, Cen J, Fang WR. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 isomers, tetrataisohydroquinolin derivatives. Biol Pharm Bull. 2008; 31 (6) 1258-64
• 15 Garrett SH, Phillips V, Somji S, Sens MA, Dutta R, Park S et al. Transient induction of metallothionein isoform 3 (MT-3), c-fos, c-jun and c-myc in human proximal tubule cells exposed to cadmium. Toxicol Lett. 2002; Jan 126 (1) 69-80
• 16 Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K et al. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer. 2004; Aug 45 (2) 181-8
• 17 Moon DO, Kim MO, Choi YH, Kim GY. ß-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways. Cancer Lett 2008; 264: 181-91
• 18 Kuang YH, Shen T, Chen X, Sodani K, Hopper-Borge E et al. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochem Pharmacol. 2010; Jan 79 (2) 154-61
• 19 Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol. 2002; Aug 64 (4) 573-82
• 20 Maire MA, Rast C, Vasseur P. Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cell. Toxicol Lett 2005; 158: 237-45
• 21 Korynevska A, Heffeter P, Matselyukh B, Elbling L, Micksche M et al. Mechanisms underlying the anticancer activities of the angucycline landomycin E. Biochem Pharmacol. 2007; Dec 74 (12) 1713-26
• 22 Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 2008; Jun 34 (4) 378-90
• 23 Lancet JE, Baer MR, Duran GE, List AF, Fielding R et al. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. Leuk Res. 2009; Aug 33 (8) 1055-61
• 24 Fang Yan WF, Juan Cen, Taijun Hang, Yunman Li. Effect of HZ08, a novel modulator of tumor multidrug resistance, on adriamycin pharmacokinetics in rats. Chin J New Drugs. 2010; 19 (23) 2170-3
• 25 Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; Apr 292 (5517) 727-30
• 26 Kyo S, Takakura M, Taira T, Kanaya T, Itoh H et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000; Feb 28 (3) 669-77
• 27 Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999; Jan 8 (1) 137-42
• 28 Meeker AK, De Marzo AM. Recent advances in telomere biology: implications for human cancer. Curr Opin Oncol. 2004; Jan 16 (1) 32-8
• 29 Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res. 2005; May 305 (2) 300-11
• 30 Xiang H, Wang J, Mao YW, Li DW. hTERT can function with rabbit telomerase RNA: regulation of gene expression and attenuation of apoptosis. Biochem Biophys Res Commun. 2000; Nov 278 (3) 503-10
• 31 Lackinger D, Kaina B. Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. Mutat Res. 2000; Dec 457 (1–2) 113-23